Showing 1 posts of 1 posts found.
The end came very quickly for the Pfizer/Allergan $160 billion deal once the US Treasury Department announced a new set …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO